These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21606178)

  • 1. Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion.
    Li Y; Ligr M; McCarron JP; Daniels G; Zhang D; Zhao X; Ye F; Wang J; Liu X; Osman I; Mencher SK; Lepor H; Wang LG; Ferrari A; Lee P
    Clin Cancer Res; 2011 Jul; 17(13):4414-24. PubMed ID: 21606178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico, in vitro and in vivo studies: Dibutyl phthalate promotes prostate cancer cell proliferation by activating Forkhead Box M1 and remission after Natura-α pretreatment.
    Bu H; Tang S; Liu G; Miao C; Zhou X; Yang H; Liu B
    Toxicology; 2023 Apr; 488():153465. PubMed ID: 36828243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H; Xiao Y
    Oncol Rep; 2017 Aug; 38(2):837-842. PubMed ID: 28677763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
    J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
    Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
    Yang F; Song L; Wang H; Wang J; Xu Z; Xing N
    PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells.
    Samykutty A; Shetty AV; Dakshinamoorthy G; Bartik MM; Johnson GL; Webb B; Zheng G; Chen A; Kalyanasundaram R; Munirathinam G
    PLoS One; 2013; 8(6):e65889. PubMed ID: 23824300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition.
    Ketola K; Munuganti RSN; Davies A; Nip KM; Bishop JL; Zoubeidi A
    Clin Cancer Res; 2017 Nov; 23(22):6923-6933. PubMed ID: 28899970
    [No Abstract]   [Full Text] [Related]  

  • 9. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.
    Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A
    Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
    Zhang Y; Won SH; Jiang C; Lee HJ; Jeong SJ; Lee EO; Zhang J; Ye M; Kim SH; Lü J
    Pharm Res; 2012 Jun; 29(6):1595-608. PubMed ID: 22281759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance.
    Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z
    FASEB J; 2020 Sep; 34(9):11511-11528. PubMed ID: 32713076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells.
    Lin CY; Huo C; Kuo LK; Hiipakka RA; Jones RB; Lin HP; Hung Y; Su LC; Tseng JC; Kuo YY; Wang YL; Fukui Y; Kao YH; Kokontis JM; Yeh CC; Chen L; Yang SD; Fu HH; Chen YW; Tsai KK; Chang JY; Chuu CP
    PLoS One; 2013; 8(6):e65734. PubMed ID: 23785446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.
    Goldberg AA; Titorenko VI; Beach A; Abdelbaqi K; Safe S; Sanderson JT
    Invest New Drugs; 2014 Feb; 32(1):25-36. PubMed ID: 23709189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
    Hadaschik BA; Ettinger S; Sowery RD; Zoubeidi A; Andersen RJ; Roberge M; Gleave ME
    Int J Cancer; 2008 May; 122(10):2368-76. PubMed ID: 18240145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo.
    Syrovets T; Gschwend JE; Büchele B; Laumonnier Y; Zugmaier W; Genze F; Simmet T
    J Biol Chem; 2005 Feb; 280(7):6170-80. PubMed ID: 15576374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer.
    Kaseb AO; Chinnakannu K; Chen D; Sivanandam A; Tejwani S; Menon M; Dou QP; Reddy GP
    Cancer Res; 2007 Aug; 67(16):7782-8. PubMed ID: 17699783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α.
    Nayeem MJ; Yamamura A; Hayashi H; Muramatsu H; Nakamura K; Sassa N; Sato M
    Life Sci; 2022 Jan; 288():120171. PubMed ID: 34822800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.